Unanticipated Difficult Airway: Can Sugammadex Rescue can’t Intubate can’t Ventilate (CICV) Scenario?

Hussain, Nageena

doi:10.4172/2155-6148.1000e109

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 17 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sugammadex will not be of value in these scenarios and preparation for emergency surgical airway management with the goal to reoxygenate the patient must also be included in the CICV algorithm. 25 The FDA has not approved the use of sugammadex for pediatric patients at this time. However, sugammadex has been used to reverse neuromuscular blockade for pediatric patients with difficult clinical scenarios as discussed in this article, including in CICV and patients with muscular dystrophy and myotonic dystrophy.…”

Section: Discussionmentioning

confidence: 99%

Sugammadex: Efficacy and Practicality in the Dental Office

Goetz

Pritts

Cornelius

2018

Anesthesia Progress

View full text Add to dashboard Cite

Sugammadex is a novel drug capable of reversing paralysis induced by the common steroidal nondepolarizing neuromuscular blocking drugs, rocuronium and vecuronium. Reversal is complete at any depth of blockade dependent on the dose of sugammadex administered. This allows rocuronium to be used as a rescue agent in scenarios where succinylcholine is contraindicated. Sugammadex is considered a safe drug with minimal side effects compared with traditional reversal with neostigmine and glycopyrrolate. This article features a case report where succinylcholine was undesirable and rapid reversal of paralysis with sugammadex was used during general anesthesia for dentistry.

show abstract

Section: Discussionmentioning

confidence: 99%